Thus, the results suggest that plxnb1 is the direct downstream mRNA target of miR-140-3p, and that miR-140-3p can rescue osteogenesis by inhibition of the sema4D/plexin B1 signaling pathway in DM-BMSCs. Here, PLXNB1 is linked to diabetes mellitus.